Epigenetic Modifications in Cancer Development
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 24 May 2024 | Viewed by 221
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is now well known that epigenetic modifications (e.g., DNA methylation, histone modifications, histone variants, etc.) play a central role in cancer initiation and progression. These modifications regulate various essential cellular processes in cancer, including cell proliferation, apoptosis, invasion and migration. These modifications are also at the heart of cancer cell heterogeneity, cancer relapse and the emergence of treatment resistance. The characterization of these modifications, and of their functions, therefore enables us to improve patient diagnosis and envisage new therapeutic avenues. For this Special Issue, we welcome review articles and original research studies exploring these aspects.
Dr. Benoit Miotto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epigenetics
- cancer
- histone
- DNA methylation
- cancer treatment
- diagnosis
- biomarkers
- resistance to treatment
- chromatin organization
